Previous 10 | Next 10 |
2024-06-17 17:58:14 ET Summary An FDA advisory committee voted 11-0 in favor of Eli Lilly and Company's donanemab for the treatment of early Alzheimer's disease. Donanemab has no effect on non-APOE4 carriers, may slow the decline of APOE4 carriers closer to that of non-carriers, a...
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Biogen To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - June 16, 2024) - Faruqi & Faruqi, LLP, a leading national se...
2024-06-15 15:37:28 ET The market for medicines to treat amyotrophic lateral sclerosis (ALS) in major markets is projected to more than surge to $1.28B in 2029 from $317M in 2019, representing a CAGR of 15%.... Read the full article on Seeking Alpha For further details see: ...
NEW YORK, NY / ACCESSWIRE / June 12, 2024 / Leading law firm Bleichmar Fonti & Auld LLP announces the upcoming July 22, 2024, deadline in the Biogen Inc. (Nasdaq:BIIB) Securities Class Action Lawsuit. If you invested in Biogen, you are encouraged to obtain additional information by visiting ...
2024-06-12 14:20:26 ET Biogen Inc. (BIIB) Goldman Sachs 45th Annual Global Healthcare Conference June 12, 2024, 10:40 AM ET Company Participants Alisha Alaimo - Head and President of North-America Chuck Triano - Head of IR Conference Call Participants Sal...
2024-06-12 12:30:03 ET Scotiabank analyst issues SECTOR OUTPERFORM recommendation for BIIB on June 12, 2024 10:10AM ET. The previous analyst recommendation was Sector Outperform. BIIB was trading at $230.28 at issue of the analyst recommendation. The overall analyst cons...
2024-06-12 12:00:07 ET George Farmer from Scotiabank issued a price target of $275.00 for BIIB on 2024-06-12 10:10:00. The adjusted price target was set to $275.00. At the time of the announcement, BIIB was trading at $230.28. The overall price target consensus is at $29...
2024-06-12 06:10:00 ET Summary The Morningstar Wide Moat Focus Index ended May, trailing the S&P 500 Index by nearly 9% thus far in 2024. The S&P 500 Equal Weighted Index is now trading at levels relative to the market cap-weighted S&P 500 Index that haven’t bee...
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Biogen To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - June 11, 2024) - Faruqi & Faruqi, LLP, a leading national se...
2024-06-11 08:45:53 ET Palm Beach, FL – June 11, 2024 – FN Media Group News Commentary – In the last twenty years, the amount of people with multiple sclerosis (MS) in the United States has more than doubled. In 2000, it was estimated by the National Multipl...
News, Short Squeeze, Breakout and More Instantly...
CAMBRIDGE, Mass., July 02, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) has completed the acquisition of Human Immunology Biosciences (HI-Bio™), a privately-held clinical-stage biotechnology company focused on targeted therapies for patients with severe immune-mediated diseases ...
TOKYO and CAMBRIDGE, Mass., June 27, 2024 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today tha...
NEW YORK, NY / ACCESSWIRE / June 12, 2024 / Leading law firm Bleichmar Fonti & Auld LLP announces the upcoming July 22, 2024, deadline in the Biogen Inc. (Nasdaq:BIIB) Securities Class Action Lawsuit. If you invested in Biogen, you are encouraged to obtain additional information by visiting ...